<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 10-Q/A
(Mark One)
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
for the quarterly period ended March 31, 1997.
Or
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(D)
OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to .
------------ ------------
Commission file number: 0-19711
THE SPECTRANETICS CORPORATION
(Exact name of registrant as specified in its charter)
Delaware 84-0997049
(State or other jurisdiction (I.R.S. Employer Identification No.)
of incorporation or organization)
96 Talamine Court, Colorado Springs, Colorado 80907
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (719) 633-8333
Indicate by check mark whether the registrant (1) has filed all reports
required to be filed by Section 13 or 15(d) of the Securities Exchange Act
of 1934 during the preceding 12 months (or for such shorter period that
the registrant was required to file such reports), and (2) has been subject
to such filing requirements for the past 90 days. Yes [X] No [ ]
As of May 5, 1997, there were 18,592,677 shares of the Registrant's
Common Stock outstanding.
<PAGE>
PART II - OTHER INFORMATION
Part II is hereby amended to add the following:
Item 5. Other Information.
The Registrant entered into a License Agreement (the "License
Agreement") with Medtronic, Inc. ("Medtronic") effective as of February 28,
1997. Pursuant to the terms and conditions of the License Agreement,
Medtronic granted to the Registrant an exclusive worldwide license to make,
have made, use and sell certain laser "lead extractor" devices for aiding in
removal of medical devices such as pacing and defibrillation leads or
catheters. The term of the License Agreement continues until the expiration,
in any country, of the last patent in the intellectual property licensed
thereunder.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
Date: July 31, 1997
THE SPECTRANETICS CORPORATION
(Registrant)
By: /s/ James P. McCluskey
---------------------------
James P. McCluskey
Vice President, Finance
Secretary/Treasurer and
Principal Financial Officer
